CD36 and obesity disorder: Fecal metabolome analysis revealed that GTC treatment reduced saturated fatty acids and improved amino acid levels, thereby supporting gut health and metabolism. Furthermore, the study demonstrated that GTC prevents obesity‐induced renal damage by modulating PPARγ/CD36 signaling and maintaining gut homeostasis in rats